4 Undervalued Pharmaceuticals Stocks for Tuesday, October 01
Discover the top 4 undervalued Pharmaceuticals stocks for Tuesday, October 01 based on AAII’s Stock Grades.Omar Beirat
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Omar Beirat
Omar Beirat
Jack Gilleland
Jenna Brashear
Jenna Brashear
| Share Statistics | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $55,619.7 | $626.3 | 94% |
|
| Shares Out (Mil) | 1,122.4 | 43.4 | 95% |
|
| Institutional Ownership | 50.0% | 83.9% | 30% |
|
| Float (Mil) | 982.4 | 45.7 | 91% |
|
| Beta | 0.83 | 0.73 | 50% |
|
| Avg Daily Volume (000s) | 344 | 309 | 54% |
|
| Price Change (52-week) |
70.3% | 66.6% | 87% |
|
| Growth | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.1% | 6.7% | 20% |
|
| Net Income (5yr) | 19.8% | (1.6%) | 73% |
|
| EPS (5yr) | 19.8% | 15.1% | 68 |
|
| Dividends (5yr) | (44.5%) | 0.0% | 57% |
|
| Cash Flow (5yr) | (13.8%) | (15.0%) | 55% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 2 | 2 | |
| Current EPS | $0.161 | $1.303 | $1.373 | |
| Month Ago EPS | $0.529 | $5.223 | $5.539 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $0.700 | $5.097 | $5.475 | |
| Year/Year Chg | na | (130.1%) | (137.0%) | |
| Financials | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $51,839 | $317 | 97% |
|
| Net Income (TTM) (Mil) | ($1,986) | ($11) | 1% |
|
| EPS (TTM) | ($2.021) | ($0.700) | 14% |
|
| Operating Cash Flow (TTM) (Mil) | $5,464 | ($6) | 95% |
|
| Net Cash Flow (TTM) (Mil) | ($237) | $6 | 9% |
|
| Long-Term Debt (Q1) (Mil) | $35,604 | $6 | 97% |
|
| Enterprise Value (Q1) (Mil) | $93,486 | $525 | 96% |
|
| Valuation | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.69 | na |
|
| P/E | na | 16.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BAYRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 60.5% | 68.8% | 73% |
|
| Net Margin | (3.8%) | (1.4%) | 26% |
|
| ROA | (1.6%) | (24.1%) | 35% |
|
| ROE | (5.7%) | (21.4%) | 30% |
|
| Liabilities to Assets | 72.3% | 33.1% | 68% |
|
| F-Score | na | 3 | na |
|
Bayer Aktiengesellschaft did not pass any screens on 9/10/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors